Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against <it>Staphylococcus aureus</it>, <it>Pseudomonas aeruginosa</it>, and <it>Stenotrophomonas maltophilia</it>
<p>Abstract</p> <p>Background</p> <p>Treatment of cystic fibrosis-associated lung infections is hampered by the presence of multi-drug resistant pathogens, many of which are also strong biofilm producers. Antimicrobial peptides, essential components of innate immunity i...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-07-01
|
Series: | BMC Microbiology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2180/12/145 |